| Element List | Explanation |
|---|---|
| Introduction | Professional Medical Expertise Company (“ProMedEx”) is pleased to announce to the shareholders that the Board of Directors issued a recommendation on 10/12/1446 AH to the General Assembly to distribute cash dividends to shareholders for the fiscal year 2024. |
| Date of the board’s recommendation | 2025-04-10 Corresponding to 1446-10-12 |
| The Total amount distributed | 3,500,000 |
| Number of Shares Eligible for Dividends | 3,500,000 |
| Dividend per share | 1 SAR |
| Percentage of Dividend to the Share Par Value (%) | 10 |
| Eligibility date | Eligibility shall be for shareholders who own shares at the end of trading on the day of the general assembly and who are registered in the company’s shareholder registry with the Securities Edaa Center Company (Edaa Center) at the end of the second trading day following the entitlement date. |
| Distribution Date | The distribution date will be determined later after the General Assembly approves the recommendation to distribute dividends. |
| The name of other official authorities and the details of their non-refusal to the recommendation or decision | We would like to draw the attention of non-resident investors to the fact that cash dividends transferred or credited to their bank accounts will be subject to a withholding tax of 5% upon transfer or credit to their bank accounts, in accordance with the provisions of Article (68) of the Income Tax Law and Article (63) of its Executive Regulations. Professional Medical Expertise Company also urges shareholders to update their data in the banking system and link bank account numbers to their investment portfolios to ensure receipt of dividends on the distribution day. For any quires, please contact Investor Relations Department at: Phone Number: 8001240448; 301; 310; 204 Email: IR@PROMEDEX.COM |
| Additional Information | - |
